AB Science announces that Health Canada has started the review of New Drug Submission for masitinib in the treatment of ALS
26/05/2022 – AB Science today announces that Health Canada has issued a screening acceptance letter for the application of masitinib in the treatment of amyotrophic lateral sclerosis (ALS)